Healthcare

Humana is a senior-focused health insurer with a powerful Medicare position and an expanding care-services platform. Revenue growth remains strong, and the long-term backdrop is favorable, but the central question is whether margins and cash flow can recover.

HCA Healthcare operates one of the largest hospital networks in the U.S., pairing steady demand for medical care with strong margins, solid revenue growth, and powerful cash generation. Its scale and dense local networks make it a notable force in hospital services.

Guardant Health develops blood-based cancer tests for screening, treatment selection, and disease monitoring. Rapid revenue growth, a strong position in liquid biopsy, and the expanding Shield opportunity make the company an important name to examine closely.

GE HealthCare is a global medical technology company centered on imaging, ultrasound, monitoring, and diagnostic agents. Strong margins, a large installed base, and practical AI and workflow opportunities make its long-term business profile worth a closer look.

Edwards Lifesciences is a heart-device specialist led by its TAVR franchise, with expanding opportunities in mitral and tricuspid therapies. Strong profitability, low debt, and a large clinical footprint make its next phase of structural heart growth especially worth examining.

Elevance Health is a major U.S. health insurer built on large-scale commercial and government coverage, with Carelon adding pharmacy and care services. Its broad reach, solid cash generation, and below-sector valuation make its long-term profile worth a closer look.

DexCom develops continuous glucose monitoring systems that bring recurring revenue, high margins, and growing cash flow. Its position in diabetes technology, expanding global reach, and room to broaden CGM use make it a company worth a closer analytical look.